Bangkok, September 15, 2025] As a professional supplier of amino acid raw materials for health products in China, huarong pharma recently showcased its core amino acid raw material products at 2025Vitasfood held in Bangkok, Thailand. This expo is the largest and most professional event for food raw materials and health ingredients in Southeast Asia, attracting over 300 exhibitors from 28 countries and regions, as well as more than 5,000 food and health product manufacturers and purchasers. With its high-purity raw material quality and strict production standards, huarong pharma became a prominent Chinese enterprise representative at the expo.
The raw material market for food and health products in Southeast Asia is in a period of rapid growth. According to data from the ASEAN Health Industry Association, the regional raw material market size reached 9 billion US dollars in 2024, with an annual growth rate of over 16%. Thailand, Malaysia, and Singapore are the core demand markets. With the vigorous development of the health product and functional food industry in Southeast Asia, the demand for amino acids, natural active ingredients and other raw materials has surged. Moreover, the market's acceptance of high-quality raw materials from countries along the "Belt and Road" continues to improve, providing broad space for Chinese raw material suppliers to enter.
At the expo, huarong pharma focused on displaying three series of amino acid raw material products: First, γ-Aminobutyric Acid (GABA) raw material, with a purity of over 99.5%, produced by biological fermentation, complying with FCC and USP standards, suitable for the production of health products and functional beverages; Second, Pyrroloquinoline Quinone (PQQ) raw material, with high activity content ≥99%, certified by third-party testing, focusing on applications in brain enhancement and mitochondrial maintenance products; Third, β-Nicotinamide Mononucleotide (NMN) raw material, with purity ≥99%, following GMP production standards, serving as the core ingredient for anti-aging health products.
Notably, during the expo, huarong pharma conducted in-depth docking with many well-known health product manufacturers and raw material importers in Southeast Asia. Among them, it held multiple rounds of negotiations with Healthtech, a large Thai health product manufacturer, on the procurement of GABA raw materials, and the two sides exchanged views on key issues such as raw material purity standards, batch stability, and supply cycles; at the same time, it held talks with Nutri Source, a Malaysian raw material importer, on the supply of PQQ and NMN raw materials, focusing on discussing cooperation details such as customized purity specifications and logistics and warehousing solutions, laying the foundation for potential cooperation in the follow-up.
Merlin, Marketing Director of huarong pharma, delivered a speech at the "Health Raw Material Innovation Application Forum" held concurrently with the expo, stating: "The Southeast Asian market is an important part of huarong's international layout. We not only bring high-quality amino acid raw materials certified by multiple international standards, but also are committed to building a full-chain cooperation system from raw material supply to technical support with local manufacturers." According to him, to ensure the quality of raw materials, huarong pharma has established a full-process traceability system "from strain research and development to finished product delivery". Customers can query raw material production batches, test reports and other information through an exclusive system. This transparency measure has been highly recognized by on-site purchasers.
Mr. Somsak Thongmee, Director of the Raw Material Administration of Food and Drugs under the Thai Ministry of Industry, visited huarong pharma's booth and pointed out: "Chinese amino acid raw materials have significant advantages in purity control and production technology. We look forward to enterprises like huarong strengthening cooperation with local health product production institutions in Thailand to jointly promote the standardization and innovative application of the regional health raw material industry." During the expo, huarong pharma also won the "2025 Asia Health Raw Material Market Potential Brand Award" issued by the organizing committee, in recognition of its outstanding performance in raw material quality and market expansion.
During this expo, huarong pharma received more than 200 procurement consultations from various ASEAN countries and conducted in-depth communication with 12 enterprises on potential raw material cooperation projects. Next, the enterprise plans to provide small-batch raw material trial services and application technical guidance for the Southeast Asian market, and optimize the regional logistics and distribution system, so that high-quality amino acid raw materials can serve local manufacturers more efficiently.
With the continuous rise of health consumption trends worldwide, the amino acid raw material market has become a new growth point in cross-border trade. Through this 2025Vitasfood, huarong pharma has further consolidated its brand foundation in the ASEAN market. Its strategy of "quality first, technology empowerment" not only opens up new growth space for the enterprise, but also provides a reference practice path for Chinese health raw materials to enter the international market.